The global dermal filler market size was worth around USD 4.8 billion in 2021 and is predicted to grow to around USD 11.7 billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.5% between 2022 and 2030.
Dermal Filler Market
The global dermal filler market size was worth around USD 4.8 Billion in 2021 and is predicted to grow to around USD 11.7 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.5% between 2022 and 2030. The report analyzes the global dermal filler market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the dermal filler market.
Get more information about this report - Request Free Sample PDF
Less invasive procedures called dermal fillers are utilized as anti-aging treatments to reduce facial lines and restore firmness. These soft tissue fillers known as dermal fillers, which include hyaluronic acid, polymers and particles, and collagen, are injected into the skin to address conditions including scars & wrinkles and smoothen the skin. A range of skin-related problems is treated with dermal filler procedures. Techniques using dermal fillers can be used to smooth skin, get rid of scars and wrinkles, and perform other operations.
Growing demand for less invasive procedures to drive the market growth
One or more minimally invasive procedures, such as neurotoxins, Dermal Fillers, deoxycholic acid, lasers, peels, and microneedling, can be effective, less invasive alternatives to surgery for some patients. Injectables and skin resurfacing techniques are used to treat a variety of facial problems, including wrinkles, fine lines, loss of volume and contour, and excess fat.
The ideal treatment strategy for a given patient must carefully take into account the patient's medical issues, unique anatomical features, tissue quality, and anticipated outcomes. An article on facial plastic surgery estimates that 1.4 million surgical and non-surgical procedures will be carried out worldwide in 2021, with plastic doctors doing an additional 600 operations per year on average. Comparing the statistics revealed a 40% increase to the previous year.
The high cost of treatment limits the market growth
Dermal filler cosmetic therapy is a well-liked and secure outpatient method for treating minor volume loss and aging signs. However, it is anticipated that the expensive price will hinder the global dermal filler market demand for these treatments. According to the American Society of Plastic Surgeons, PMMA [Poly (Methyl Methacrylate)] costs $981, Calcium Hydroxylapatite costs $717, Fat Fillers cost $2,508, Hyaluronic Acid costs $684, Poly-L-lactic Acid costs $853, and polymethyl-methacrylate microspheres cost $1,058. Depending on the type and quantity used during treatment, dermal filler prices can vary. Thus, the high cost of treatments is expected to impede market growth over the forecast period.
Innovation in dermal fillers provides a lucrative opportunity
Dermal fillers are gel-like materials that are injected beneath the skin to replenish lost volume, smooth out wrinkles, and soften lines. More than a million people choose this well-known cosmetic transformation procedure each year to remove wrinkles and improve the appearance of facial lines to enhance facial features. Dermal fillers are a successful procedure that can make you seem younger without surgery or recovery time. Dermal fillers are medications that are injected beneath the skin to fill in face creases. Dermal filler medications come in a variety of forms, the most popular being calcium hydroxylapatite, hyaluronic acid, polyalkylimide, polylactic acid, and others. Dermal filler brand advancement will support increased market demand.
The dearth of skilled professionals acts as a major challenge
There are many different types of aesthetic treatment methods, including laser-based technology, energy-based technology, and powerful pulse light. For any of these techniques to be used effectively, the practitioner must possess strong interpersonal skills. Additionally, the field's rapid technological development has resulted in a shortage of qualified specialists. The handling of surgical instruments and performing procedures are both significantly hampered by a lack of competent experts.
The global dermal filler market is segmented based on type, material type, application, end-user, and region.
Based on the type, the global market is bifurcated into biodegradable and non-biodegradable. The biodegradable segment accounted for the largest market share in 2021 and is expected to show its dominance during the forecast period. The growth in the segment is attributed to the more product options being offered, as well as the increasing usage of biodegradable materials for aesthetic purposes. Biodegradable products are created entirely of natural materials and are applied topically to the skin, hair, face, and mouth. On the other hand, the non-biodegradable segment is projected to grow at the fastest CAGR during the forecast period.
The growth in the non-biodegradable segment is attributed to the product's long-lasting quality. Non-biodegradable substances do not degrade and remain in the body for a longer period than temporary and semi-permanent fillers.
Based on the material type, the dermal filler industry is bifurcated into hyaluronic acid, calcium hydroxylapatite, poly-l-lactic acid, PMMA [Poly (Methyl Methacrylate)], and others.
Based on the application, the global dermal filler is divided into facial line correction treatment, face-lift, scar treatment, wrinkle correction treatment, lip enhancement, and others. The wrinkle correction treatment segment maintained the greatest revenue market share in 2021, owing to increased demand for these treatments among the aging population. According to Cosmetic Executive Women (CEW) news from 2021, an average of 943,500 searches for aging-related concerns in the skin care area are conducted in the United States each month. Besides, the Lip Enhancement category is expected to develop at the quickest CAGR throughout the projected period, owing to the increasing frequency of lip treatments and the growing demand for cosmetic lip enhancements.
Based on the end user, the global market is segmented into dermatology clinics, hospitals, and others.
|Report Attributes||Report Details|
|Report Name||Dermal Filler Market Research Report|
|Market Size in 2021||USD 4.8 Billion|
|Market Forecast in 2030||USD 11.7 Billion|
|Compound Annual Growth Rate||CAGR of 10.5%|
|Number of Pages||190|
|Forecast Units||Value (USD Billion), and Volume (Units)|
|Key Companies Covered||Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., Anika Therapeutics, Inc, FillMed Laboratories, Ipsen Pharma, BIOXIS Pharmaceuticals, Zhejiang Jingjia Medical Technology Co. Ltd., Zimmer Aesthetic, Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Galderma Laboratories, L.P., Croma-Pharma GmbH, Teoxane, BioPlus Co., Ltd., among others.|
|Segments Covered||By Type, By Material Type, By Application, By End User, And By Region|
|Regions Covered||North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA)|
|Countries Covered||North America: U.S and Canada
Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe
APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific
Latin America: Brazil, Argentina, Chile
The Middle East And Africa: South Africa, GCC, Rest of MEA
|Historical Year||2016 to 2020|
|Forecast Year||2022 - 2030|
|Customization Scope||Avail customized purchase options to meet your exact research needs. Request For Customization|
North America is expected to dominate the market during the forecast period
Throughout the predicted period, North America is anticipated to rule the global dermal filler market. An extremely aware and financially secure people is one component of this region's supremacy. For instance, 15.6 million cosmetic treatments were carried out in the United States in 2020, according to the American Society of Plastic Surgeons (ASPS). Additionally, the region's growth is anticipated to be fueled by new product releases and regulatory clearances during the projected period.
For instance, The US Food and Drug Administration (FDA) declared RHA Redensity to be approved. RHA Redensity, a gel implant or dermal filler made by the Swiss hyaluronic acid product manufacturer Teoxane, is injected into particular areas of facial tissue to minimize the appearance of lines and wrinkles. Sodium hyaluronic acid (NaHA), 1,4-butanediol diglycidyl ether (BDDE), and 0.3% of the medication lidocaine hydrochloride are included in it. Thus, the fast product approval by the regulatory authorities will flourish the market expansion over the forecast period.
The second-highest market share is expected to be held by Europe, which can be attributed to rising consumer interest in Dermal Fillers procedures in important European countries and rising R&D spending there. However, it is anticipated that the Asia Pacific region will have phenomenal growth during the predicted period. The region's market is expanding due to the improved healthcare infrastructure in Asian countries, the rapidly aging population, and the increasing awareness of people about their physical presence. For instance, as per World Health Organization (WHO), in the South-East Asia Region, the population is aging quickly. While the percentage of adults 60 and older was 9.8% in 2017, it will rise to 13.7% and 20.3%, respectively, by 2030 and 2050.
The global dermal filler market is dominated by players like:
By Material Type
By End User
The dermal filler market is expanding, which may be attributable to factors like the less painful manner of treating different face skin disorders, the low incidence of complications following surgery, the low level of pain, the need for smaller incisions, and the low level of discomfort.
According to the report, the global market size was worth around USD 4.8 billion in 2021 and is predicted to grow to around USD 11.7 billion by 2030 with a compound annual growth rate (CAGR) of roughly 10.5% between 2022 and 2030.
The global dermal filler market growth is expected to be driven by North America. It is currently the world’s highest revenue-generating market owing to the increasing ageing population in the region.
The global dermal filler market is dominated by players like Prollenium Medical Technologies, Suneva Medical, Revance Therapeutics, Inc., Anika Therapeutics, Inc, FillMed Laboratories, Ipsen Pharma, BIOXIS Pharmaceuticals, Zhejiang Jingjia Medical Technology Co. Ltd., Zimmer Aesthetic, Medytox, Contura International ltd., Shanghai Reyoungel Medical Technology Company Limited, Galderma Laboratories, L.P., Croma-Pharma GmbH, Teoxane, BioPlus Co., Ltd., among others.
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed